Clinical Trial Results: Gastric Cancer

Product Name: Avastin [bevacizumab]
Date of Report: To be Published
Phase: III
A Study of Avastin (Bevacizumab) in Combination With Xeloda (Capecitabine) and Cisplatin in Patients With Advanced Gastric Cancer.

Product Name: Herceptin [trastuzumab]
Date of Report: To be Published
Phase: III
ToGA study A Study of Herceptin (Trastuzumab) in Combination With Chemotherapy Compared With Chemotherapy Alone in Patients With HER2-Positive Advanced Gastric Cancer

Product Name: Herceptin [trastuzumab]
Date of Report: To be Published
Phase: II
A Study of Herceptin (Trastuzumab) in Patients With Metastatic or Advanced Gastric Cancer With Disease Progression

Product Name: Xeloda [capecitabine]
Date of Report: To be Published
Phase: III
A Study of Xeloda (Capecitabine) in Patients With Advanced or Metastatic Gastric Cancer

Product Name: Xeloda [capecitabine]
Date of Report: To be Published
Phase: III
A Study of Xeloda (capecitabine) in Combination Chemotherapy Versus Surgery Alone in Patients With Gastric Cancer

Product Name: Xeloda [capecitabine]
Date of Report: To be Published
Phase: II
A Study of Xeloda (Capecitabine) as First-Line Chemotherapy in Patients With Advanced or Metastatic Gastric Cancer.

Product Name: Xeloda [capecitabine]
Date of Report: To be Published
Phase: II
A Study of Xeloda (Capecitabine) in Combination With Chemotherapy in Patients With Advanced and/or Metastatic Gastric Cancer.